Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest bloating Stories

2012-07-25 23:03:14

Bowtrol review of the colon cleanse product and home remedy has been released. People want to know is Bowtrol colon cleanse the best one or is the whole thing a scam. Its revealed on HealthAvenger.com. Houston, TX (PRWEB) July 25, 2012 Bowtrol reviews for the colon cleansing product have flooded the market as many people are getting great results from the product. Bowtrol colon cleanse is a highly effective herbal combination used to moisten, lubricate and cleanse the intestinal tract...

2012-05-24 10:24:10

New Resource Center from the American College of Gastroenterology Addresses Common Digestive Troubles BETHESDA, Md., May 24, 2012 /PRNewswire-USNewswire/ -- The American College of Gastroenterology has created a special online resource center that features the College's wealth of scientifically-based education material and information, the latest related research from The American Journal of Gastroenterology and expert insight to help patients understand common gastrointestinal (GI)...

2012-05-18 02:24:20

SAN DIEGO, May 18, 2012 /PRNewswire/ -- Ocera Therapeutics Inc., a privately-held biopharmaceutical company focused on the development and commercialization of proprietary agents to treat gastrointestinal and liver diseases, announced today that it has received a CE Mark for Zysa(TM) (spherical carbon adsorbent, formerly AST-120) for the treatment of diarrhea predominant IBS (IBS-d), a condition affecting 10-15% of the Western world. Zysa is now ready for clinical use in the EU and countries...

2012-04-12 06:26:18

SAN DIEGO, April 12, 2012 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. today announced the closing of a $10 million Series B equity financing led by new investor Thomas, McNerney & Partners, which invested $8 million in the round. In connection with the financing, Jason Brown, Ph.D., principal at Thomas, McNerney & Partners, has joined Tioga's board of directors. Existing investor Genesys Capital Partners also participated in the financing. Tioga is currently conducting a...

2012-03-21 02:24:49

MILWAUKEE, March 21, 2012 /PRNewswire/ -- High numbers of veterans returning from the Gulf War regions of Iraq and Afghanistan are experiencing symptoms of irritable bowel syndrome (IBS) and other functional gastrointestinal (GI) disorders. This prompted the Department of Veterans Affairs (VA) last August to implement a new rule for the purposes of assessing disability benefits. Veterans deployed during the Gulf War who now suffer with a functional GI disorder are presumed to have developed...

2011-11-21 12:26:30

A patient's viewpoint of the severity of irritable bowel syndrome (IBS) symptoms can be influenced not only by physical symptoms of IBS but broader psychological problems, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. "Clinicians who face pressure to treat patients in a cost-effective manner within tight time constraints and at a satisfactory level are likely to find that patient-reported outcome...

2011-11-02 09:10:45

Among the most commonly used treatments for IBS, a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers Among the most commonly used treatments for irritable bowel syndrome — which affects as many as 20 percent of the United States population — a targeted antibiotic was shown to be the safest in a new study by Cedars-Sinai researchers, based on an analysis of 26 large-scale clinical trials. The study, for presentation at the American...

2011-11-01 08:54:00

MORRISTOWN, N.J., Nov. 1, 2011 /PRNewswire/ -- Nothing kills the mood quicker than a stomach "issue" because when you feel bloated, uncomfortable or gassy, it's challenging to feel your best or most attractive. In fact, according to a recent survey conducted by Braun Research, more than 25 percent of Americans report avoiding intimacy due to constipation. Phillips'® Colon Health®, a brand of Bayer Healthcare, today announced several findings related to...

2011-09-29 05:55:00

BARCELONA, Spain, September 29, 2011 /PRNewswire/ -- - Linaclotide has demonstrated statistically significant improvement in abdominal pain/discomfort and global relief of IBS-C symptoms in Phase III clinical trials [1,2] - IBS-C is a debilitating disease associated with reduced quality of life and considerable socio-economic and psychological consequences [3,4] Almirall, S.A. (ALM.MC) announced today that it has submitted a Marketing Authorisation Application...

2011-06-16 07:00:00

SAN DIEGO, June 16, 2011 /PRNewswire/ -- Tioga Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued Patent No.7,960,429 "KAPPA-OPIATE AGONISTS FOR THE TREATMENT OF DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME." This patent covers the use of asimadoline to treat diarrhea predominant irritable bowel syndrome (D-IBS) and has an expiration date in June, 2028. The recently issued patent is owned by Tioga Pharmaceuticals. A continuation...